This volume in the Milestones in Drug Therapy series describes the past 20 years of treatment with recombinant human G-CSF, including basic science, the use of G-CSF in both the oncology and non-oncology settings, and the safety and economics of its use.In that study, no difference was found between infection rates in HIV patients during neutropenic periods compared with ... for HIV-infected outpatients stratified by ANC, using ICD-9 codes to evaluate for the presence of infection. A total of 2047anbsp;...
|Title||:||Twenty Years of G-CSF|
|Author||:||Graham Molineux, MaryAnn Foote, Tara Arvedson|
|Publisher||:||Springer Science & Business Media - 2012-01-05|